ZOMDF insider transaction filings
Zomedica Corp. — 29 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen ZOMDF transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Blair Anthony K — COO | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | Klass Russell Kevin — Sr Vice President, Sales | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-08-07 | 4 | DeHaan-Fullerton Karen — General Counsel | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Klass Russell Kevin — Sr. Vice President, Sales | Purchase (P): 104,000 @ $0.10 | EDGAR |
| 2026-05-21 | 4 | Klass Russell Kevin | Purchase (P): 200,000 @ $0.10 · Purchase (P): 11,399 @ $0.11 · Purchase (P): 5,500 @ $0.10 | EDGAR |
| 2026-05-21 | 4 | POWERS JOHNNY D — Director | Purchase (P): 100,000 @ $0.10 · Purchase (P): 2,485 @ $0.10 · Purchase (P): 97,515 @ $0.10 | EDGAR |
| 2026-05-14 | 4 | POWERS JOHNNY D — Director | Purchase (P): 100,000 @ $0.10 · Purchase (P): 200,000 @ $0.11 | EDGAR |
| 2026-05-11 | 4 | POWERS JOHNNY D — Director | Purchase (P): 108,871 @ $0.11 · Purchase (P): 391,129 @ $0.11 | EDGAR |
| 2025-11-18 | 4 | Nichols Pamela — Director | Grant/award (A): 1,823,107 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | MACLEOD CHRISTOPHER ROSS — Director | Grant/award (A): 1,823,107 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Cohen Robert — Director | Grant/award (A): 1,823,107 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Williams Rodney James — Director | Grant/award (A): 1,975,033 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Rowe Jeffrey M — Director | Grant/award (A): 2,126,959 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Whelan Sean — Director | Grant/award (A): 1,975,033 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | POWERS JOHNNY D — Director | Grant/award (A): 1,823,107 (derivative) @ $0 | EDGAR |
| 2025-11-14 | 4 | Klass Russell Kevin — Sr Vice President, Sales | Purchase (P): 150,000 @ $0.10 | EDGAR |
| 2025-11-12 | 4 | Klass Russell Kevin — Sr Vice President, Sales | Purchase (P): 120,000 @ $0.10 | EDGAR |
| 2025-11-10 | 4 | Klass Russell Kevin — Sr Vice President, Sales | Purchase (P): 5,000 @ $0.10 | EDGAR |
| 2025-11-07 | 4 | Klass Russell Kevin — Sr Vice President, Sales | Purchase (P): 253,007 @ $0.08 | EDGAR |
| 2025-08-13 | 4 | Klass Russell Kevin — Sr Vice President, Sales | Purchase (P): 60,723 @ $0.04 · Purchase (P): 250,000 @ $0.04 · Purchase (P): 745,341 @ $0.04 | EDGAR |
| 2025-08-12 | 4 | Klass Russell Kevin — Sr Vice President of Sales | Purchase (P): 250,000 @ $0.04 · Purchase (P): 250,000 @ $0.04 | EDGAR |
| 2025-08-12 | 4 | Klass Russell Kevin — Sr Vice President of Sales | Purchase (P): 500,000 @ $0.04 | EDGAR |
| 2025-06-16 | 4 | Klass Russell Kevin — Sr Vice President of Sales | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | DeHaan-Fullerton Karen — General Counsel | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Blair Anthony K — COO | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | HEATON LARRY C II — CEO, Director | Grant/award (A): 4,000,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Blair Anthony K — COO | Purchase (P): 36,250 @ $0.05 · Purchase (P): 63,750 @ $0.05 | EDGAR |
| 2025-05-20 | 4 | DeHaan-Fullerton Karen — General Counsel/Corporate Secy | Purchase (P): 104,300 @ $0.05 | EDGAR |
| 2025-05-20 | 4 | POWERS JOHNNY D — Director | Purchase (P): 500,000 @ $0.05 | EDGAR |
Recent 8-K events — Zomedica Corp.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ZOMDF returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →